MMI Co-Founder, John Hipp, PhD to be Guest Editor for Special Issue of Bioengineering! Submit by 01/31/27!
MMI and HCIR continue to expand their combined impact in cardiovascular clinical trials.
MMI’s peripheral vascular experts discuss imaging assessments for evaluating structural and functional changes in vessels.
Medtronic has just announced its first FDA approval for an MRI-friendly internal defibrillator.
A recent study shows that the high up-front cost of robotic cardiac surgical solutions is offset by lower post-surgery costs.
Leadless pacemakers represent an exciting new frontier for cardiac devices.
